Skip to main content
. 2018 Sep 11;119(5):646–656. doi: 10.1038/s41416-018-0240-5

Table 2.

Hazard ratio (HR) with 95% confidence interval (CI) for obesity-related cancer risk by body mass index (BMI) category at enrolment

Model 1 age-adjusted Model 2 multivariable
N Cancer cases HR 95% CI N Cancer cases HR 95% CI
Overall obesity-related cancer a
 Underweight 3022 173 0.95 0.82–1.10 2626 149 0.92 0.78–1.08
 Normal weight 87,595 5689 1.00 Reference 77,064 4961 1.00 Reference
 Overweight 34,656 2603 1.10 1.05–1.15 29,517 2154 1.09 1.03–1.14
 Obesity 10,435 863 1.26 1.17–1.35 8706 699 1.24 1.14–1.34
 5 BMI unit increment 135,708 9328 1.11 1.08–1.14 117,913 7 963 1.10 1.07–1.13
Postmenopausal breast cancer b
 Underweight 899 27 0.96 0.66–1.41 650 19 0.98 0.62–1.55
 Normal weight 32,831 1047 1.00 Reference 24,224 730 1.00 Reference
 Overweight 19,270 638 1.04 0.95–1.15 14,079 448 1.13 1.00–1.27
 Obesity 6331 206 1.07 0.92–1.24 4540 139 1.20 1.00–1.44
 5 BMI unit increment 59,331 1918 1.03 0.97–1.08 43,493 1 336 1.07 1.00–1.15
Colorectal cancer c
 Underweight 3022 39 1.11 0.80–1.52 2902 38 1.10 0.80–1.52
 Normal weight 87,595 1 146 1.00 Reference 83,411 1083 1.00 Reference
 Overweight 34,656 585 1.12 1.02–1.24 32,511 544 1.12 1.01–1.25
 Obesity 10,435 157 1.05 0.88–1.24 9744 140 1.01 0.84–1.20
 5 BMI unit increment 135,708 1 927 1.05 0.99–1.11 128,568 1 805 1.04 0.98–1.11
Colon cancer d
 Underweight 3022 26 1.14 0.77–1.69 3017 26 1.13 0.76–1.67
 Normal weight 87,595 746 1.00 Reference 87,355 743 1.00 Reference
 Overweight 34,656 414 1.20 1.06–1.36 34,481 411 1.21 1.07–1.37
 Obesity 10,435 104 1.05 0.85–1.29 10,378 103 1.06 0.86–1.30
 5 BMI unit increment 135,708 1 290 1.06 0.99–1.14 135,231 1 283 1.07 0.99–1.14
Rectal cancer e
 Underweight 3022 13 1.05 0.60–1.82 2805 11 0.99 0.54–1.81
 Normal weight 87,595 400 1.00 Reference 79,948 354 1.00 Reference
 Overweight 34,656 171 0.98 0.82–1.18 30,665 153 1.02 0.84–1.24
 Obesity 10,435 53 1.05 0.78–1.40 9189 44 1.03 0.75–1.42
 5 BMI unit increment 135,708 637 1.03 0.93–1.14 122,607 562 1.04 0.93–1.16
Endometrial cancer f
 Underweight 2914 11 0.62 0.34–1.13 2594 10 0.63 0.34–1.18
 Normal weight 83,620 539 1.00 Reference 74,239 489 1.00 Reference
 Overweight 32,163 321 1.50 1.30–1.72 27,991 277 1.45 1.24–1.68
 Obesity 9617 186 3.02 2.55–3.58 8326 156 2.78 2.30–3.35
 5 BMI unit increment 128,314 1057 1.53 1.45–1.62 113150 932 1.51 1.42–1.60
Ovarian cancer g
 Underweight 2991 11 0.75 0.41–1.36 2851 10 0.71 0.38–1.33
 Normal weight 86,442 429 1.00 Reference 81,300 404 1.00 Reference
 Overweight 33,816 149 0.91 0.75–1.10 31,608 142 0.92 0.76–1.12
 Obesity 10,118 53 1.13 0.85–1.51 9425 49 1.09 0.81–1.48
 5 BMI unit increment 133,367 642 1.01 0.91–1.12 125,148 605 1.00 0.90–1.12
Pancreatic cancer c
 Underweight 3059 5 0.75 0.31–1.83 2902 4 0.55 0.20–1.48
 Normal weight 88,480 213 1.00 Reference 83,411 202 1.00 Reference
 Overweight 35,092 104 1.11 0.87–1.41 32,511 97 1.18 0.92–1.51
 Obesity 10,574 28 1.05 0.70–1.56 9744 29 1.19 0.79–1.79
 5 BMI unit increment 135,708 350 1.02 0.89–1.17 128,568 324 1.11 0.96–1.27
Kidney cancer h
 Underweight 3059 2 0.40 0.10–1.60 2295 2 0.50 0.12–2.04
 Normal weight 88,480 158 1.00 Reference 68,745 120 1.00 Reference
 Overweight 35,092 94 1.41 1.08–1.82 26,124 62 1.32 0.96–1.81
 Obesity 10,574 38 1.97 1.38–2.83 7502 27 1.95 1.26–3.02
 5 BMI unit increment 135,708 292 1.34 1.18–1.51 104,666 211 1.33 1.15–1.54

aModel 2 for overall obesity-related cancer was adjusted for age, education, physical activity and smoking status

bOnly in women who were postmenopausal at enrolment, model 2 for postmenopausal breast cancer was adjusted for age, education, alcohol intake, parity/age at first full-term pregnancy, oral contraceptive use, hormone therapy use and history of breast cancer in the mother

cModel 2 for colorectal and pancreatic cancer was adjusted for age, education and smoking status

dModel 2 for colon cancer was adjusted for age and smoking status

eModel 2 for rectal cancer was adjusted for age, education and alcohol intake

fModel 2 for endometrial cancer was adjusted for age, education, age at menarche, parity/age at first full-term pregnancy, oral contraceptive use and menopausal status

gModel 2 for ovarian cancer was adjusted for age, parity/age at first full-term pregnancy and oral contraceptive use

hModel 2 for kidney cancer was adjusted for age, smoking status and diabetes

The Norwegian Women and Cancer study, 1991–2014 (n = 135,708)